Clinical Trial Update: A Study of ASKG712 in Patients With Neovascular Age-Related Macular Degeneration [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating ASKG712 for Neovascular Age-related Macular Degeneration is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• ASKG712

Snippet

Sponsor: AskGene Pharma, Inc. | Conditions: Neovascular Age-related Macular Degeneration | Phase 1 | Status: ACTIVE_NOT_RECRUITING